Modular Medical Strengthens Board with Generic Insulin Expert Jeff Goldberg
Key Insights
Modular Medical (search) appointed Jeff Goldberg, Chairman of generic pharmaceutical manufacturer Lannett Company (search), to its Board of Directors to advance affordable insulin delivery technology.
Goldberg brings decades of experience in drug-device combinations and has helped Lannett make significant strides in launching generic insulin products.
The appointment supports Modular Medical (search)'s mission to simplify insulin delivery with its FDA-cleared patch pump designed for "almost-pumpers" seeking user-friendly diabetes care solutions.
Modular Medical (search), Inc. (Nasdaq:MODD) announced the appointment of Jeff Goldberg to its Board of Directors, bringing decades of healthcare and medical device leadership experience to the insulin delivery technology company. Goldberg's expertise in generic insulin development and drug-device combinations aligns with Modular Medical's mission to make insulin delivery more affordable and accessible through its FDA-cleared patch pump technology.
Strategic Leadership Addition
"We are pleased to welcome Jeff Goldberg to the Modular Medical (search) board," said Jeb Besser, CEO of Modular Medical. "Jeff's unique background at the intersection of affordable drug-device combinations will be instrumental, as we advance our mission to simplify insulin delivery and improve diabetes care worldwide."
Goldberg currently serves as Chairman of Lannett Company (search), Inc., a generic pharmaceutical manufacturer where he has helped execute a post-restructuring turnaround. During his tenure, Lannett has made significant strides in launching a generic insulin product, progress that aligns closely with Modular Medical (search)'s commitment to innovation and affordability in diabetes care.
Extensive Medical Technology Background
Goldberg's career in medical technology began alongside pioneering medical entrepreneur Alfred E. Mann, founder of MiniMed (search). He previously served as President and CEO within Mann's incubator, IncuMed (search), where he oversaw multiple portfolio companies focused on drug-device combination products, including an insulin patch-pump program. His tenure with Mann's enterprises included pivotal roles in regulatory strategy, operations turnaround, and successful exits, demonstrating his ability to guide early-stage technologies to commercial viability.
"Modular Medical (search) is advancing a truly disruptive approach to insulin delivery," said Goldberg. "I'm excited to join the board and contribute to the Company's journey toward simplifying treatment for people living with diabetes, particularly as the industry shifts toward more accessible and patient-friendly solutions."
Addressing Diabetes Care Accessibility
Modular Medical (search) positions itself as a development-stage medical device company developing the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, making top quality insulin delivery both affordable and simple to learn. The company's mission focuses on improving access to the highest standard of glycemic control for people with diabetes, extending beyond "superusers" to provide "diabetes care for the rest of us."
The company's FDA-cleared patch pump is designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design. Modular Medical (search) was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer who previously founded Tandem Diabetes (search) in 2005 and invented and designed its insulin pump.
Goldberg also serves on the boards of several healthcare and consumer-focused companies, including ATI Physical Therapy, Cano Health, and Eating Recovery Centers. He holds a JD from UCLA School of Law and an AB from Harvard College.